
Twist Bioscience Corporation TWST
$ 32.15
-2.13%
Annual report 2025
added 11-17-2025
Country |
|
IPO year |
2018 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
59.8 M |
Market Cap[1] |
$ 1.92 B |
EBITDA (LTM) |
$ -170 M |
P/E (LTM) |
-14.31 |
P/S (LTM) |
5.53 |
EPS (LTM) |
-2.32 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Brainsway Ltd.
BWAY
|
$ 18.98 | -0.32 % | $ 99.4 M | Nasdaq Global Select Market | ||
|
Burning Rock Biotech Limited
BNR
|
$ 20.62 | 0.26 % | $ 222 M | Nasdaq Global Market | ||
|
Co-Diagnostics
CODX
|
$ 0.18 | -21.16 % | $ 5.28 M | Nasdaq Capital Market | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Castle Biosciences
CSTL
|
$ 39.31 | 0.1 % | $ 1.09 B | Nasdaq Global Market,SPB | ||
|
Danaher Corporation
DHR
|
$ 230.67 | 0.02 % | $ 169 B | NYSE,SPB | ||
|
DarioHealth Corp.
DRIO
|
$ 10.7 | 2.0 % | $ 304 M | Nasdaq Capital Market | ||
|
BioNano Genomics
BNGO
|
$ 1.5 | 0.67 % | $ 1.91 M | Nasdaq Capital Market,SPB | ||
|
Exact Sciences Corporation
EXAS
|
$ 101.9 | -0.03 % | $ 18.9 B | Nasdaq Capital Market,SPB | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
DexCom
DXCM
|
$ 67.06 | -0.61 % | $ 25.9 B | Nasdaq Global Select Market,SPB | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Fulgent Genetics
FLGT
|
$ 26.49 | -0.41 % | $ 801 M | Nasdaq Global Market | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
CareDx, Inc
CDNA
|
$ 19.07 | -0.68 % | $ 1.03 B | Nasdaq Global Market,SPB | ||
|
Celcuity
CELC
|
$ 99.92 | -1.61 % | $ 3.94 B | Nasdaq Global Select Market | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
Anixa Biosciences
ANIX
|
$ 3.12 | -1.89 % | $ 99.5 K | Nasdaq Capital Market | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
IQVIA Holdings
IQV
|
$ 227.69 | 0.26 % | $ 41.3 B | NYSE,SPB | ||
|
Guardant Health
GH
|
$ 100.6 | -0.78 % | $ 12.3 B | Nasdaq Global Select Market,SPB | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Myriad Genetics
MYGN
|
$ 6.17 | -2.22 % | $ 559 M | Nasdaq Global Select Market,SPB | ||
|
ENDRA Life Sciences
NDRA
|
$ 4.76 | -1.24 % | $ 2.56 M | Nasdaq Global Select Market | ||
|
Neogen Corporation
NEOG
|
$ 7.05 | -2.35 % | $ 1.53 B | Nasdaq Global Select Market,SPB | ||
|
Koninklijke Philips N.V.
PHG
|
$ 27.39 | 0.48 % | $ 20 B | NYSE | ||
|
Personalis
PSNL
|
$ 7.97 | 0.5 % | $ 472 M | Nasdaq Global Select Market | ||
|
Quidel Corporation
QDEL
|
$ 29.3 | - | $ 1.23 B | Nasdaq Global Select Market,SPB | ||
|
National Research Corporation
NRC
|
$ 18.65 | -1.69 % | $ 458 M | Nasdaq Global Select Market | ||
|
RadNet
RDNT
|
$ 71.49 | -1.81 % | $ 5.22 B | Nasdaq Global Select Market | ||
|
Illumina
ILMN
|
$ 132.75 | -1.29 % | $ 21.1 B | Nasdaq Global Select Market,SPB | ||
|
Charles River Laboratories International
CRL
|
$ 201.98 | -0.58 % | $ 10.4 B | NYSE,SPB | ||
|
Soleno Therapeutics
SLNO
|
$ 46.29 | -2.65 % | $ 1.86 B | Nasdaq Capital Market | ||
|
Quest Diagnostics Incorporated
DGX
|
$ 175.49 | -0.02 % | $ 19.5 B | NYSE,SPB | ||
|
Biodesix
BDSX
|
$ 6.72 | -2.04 % | $ 871 M | Nasdaq Global Market | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 253.07 | 0.04 % | $ 21.2 B | NYSE,SPB | ||
|
ICON Public Limited Company
ICLR
|
$ 183.0 | 0.35 % | $ 15.1 B | Nasdaq Global Select Market,SPB | ||
|
IDEXX Laboratories
IDXX
|
$ 682.32 | -0.81 % | $ 56.3 B | Nasdaq Global Select Market,SPB | ||
|
Lantheus Holdings
LNTH
|
$ 67.16 | -0.27 % | $ 4.65 B | Nasdaq Global Select Market,SPB | ||
|
Mettler-Toledo International
MTD
|
$ 1 414.32 | -0.36 % | $ 30 B | NYSE,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.